The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Metabolic Diseases

Orphan nuclear receptor 4A1 (NR4A1) is a transcriptional factor of the nuclear orphan receptor (NR4A) superfamily that has sparked interest across different research fields in recent years. Several studies have demonstrated that ligand-independent NR4A1 is an immediate-early response gene and the pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Lei Zhang, Qun Wang, Wen Liu, Fangyan Liu, Ailing Ji, Yanzhang Li
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2018/9363461
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561239305224192
author Lei Zhang
Qun Wang
Wen Liu
Fangyan Liu
Ailing Ji
Yanzhang Li
author_facet Lei Zhang
Qun Wang
Wen Liu
Fangyan Liu
Ailing Ji
Yanzhang Li
author_sort Lei Zhang
collection DOAJ
description Orphan nuclear receptor 4A1 (NR4A1) is a transcriptional factor of the nuclear orphan receptor (NR4A) superfamily that has sparked interest across different research fields in recent years. Several studies have demonstrated that ligand-independent NR4A1 is an immediate-early response gene and the protein product is rapidly induced by a variety of stimuli. Hyperfunction or dysfunction of NR4A1 is implicated in various metabolic processes, including carbohydrate metabolism, lipid metabolism, and energy balance, in major metabolic tissues, such as liver, skeletal muscle, pancreatic tissues, and adipose tissues. No endogenous ligands for NR4A1 have been identified, but numerous compounds that bind and activate or inactivate nuclear NR4A1 or induce cytoplasmic localization of NR4A1 have been identified. This review summarizes recent advances in our understanding of the molecular biology and physiological functions of NR4A1. And we focus on the physiological functions of NR4A1 receptor to the development of the metabolic diseases, with a special focus on the impact on carbohydrate and lipid metabolism in skeletal muscle, liver, adipose tissue, and islet.
format Article
id doaj-art-aa670e5bf4604c46902c98910dbdada3
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-aa670e5bf4604c46902c98910dbdada32025-02-03T01:25:31ZengWileyJournal of Diabetes Research2314-67452314-67532018-01-01201810.1155/2018/93634619363461The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Metabolic DiseasesLei Zhang0Qun Wang1Wen Liu2Fangyan Liu3Ailing Ji4Yanzhang Li5Henan University School of Basic Medical Sciences, Henan University Joint National Laboratory for Antibody Drug Engineering, Kaifeng 475004, ChinaHenan University School of Basic Medical Sciences, Henan University Joint National Laboratory for Antibody Drug Engineering, Kaifeng 475004, ChinaHenan University School of Basic Medical Sciences, Henan University Joint National Laboratory for Antibody Drug Engineering, Kaifeng 475004, ChinaHenan University School of Basic Medical Sciences, Henan University Joint National Laboratory for Antibody Drug Engineering, Kaifeng 475004, ChinaHenan University School of Basic Medical Sciences, Henan University Joint National Laboratory for Antibody Drug Engineering, Kaifeng 475004, ChinaHenan University School of Basic Medical Sciences, Henan University Joint National Laboratory for Antibody Drug Engineering, Kaifeng 475004, ChinaOrphan nuclear receptor 4A1 (NR4A1) is a transcriptional factor of the nuclear orphan receptor (NR4A) superfamily that has sparked interest across different research fields in recent years. Several studies have demonstrated that ligand-independent NR4A1 is an immediate-early response gene and the protein product is rapidly induced by a variety of stimuli. Hyperfunction or dysfunction of NR4A1 is implicated in various metabolic processes, including carbohydrate metabolism, lipid metabolism, and energy balance, in major metabolic tissues, such as liver, skeletal muscle, pancreatic tissues, and adipose tissues. No endogenous ligands for NR4A1 have been identified, but numerous compounds that bind and activate or inactivate nuclear NR4A1 or induce cytoplasmic localization of NR4A1 have been identified. This review summarizes recent advances in our understanding of the molecular biology and physiological functions of NR4A1. And we focus on the physiological functions of NR4A1 receptor to the development of the metabolic diseases, with a special focus on the impact on carbohydrate and lipid metabolism in skeletal muscle, liver, adipose tissue, and islet.http://dx.doi.org/10.1155/2018/9363461
spellingShingle Lei Zhang
Qun Wang
Wen Liu
Fangyan Liu
Ailing Ji
Yanzhang Li
The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Metabolic Diseases
Journal of Diabetes Research
title The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Metabolic Diseases
title_full The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Metabolic Diseases
title_fullStr The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Metabolic Diseases
title_full_unstemmed The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Metabolic Diseases
title_short The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Metabolic Diseases
title_sort orphan nuclear receptor 4a1 a potential new therapeutic target for metabolic diseases
url http://dx.doi.org/10.1155/2018/9363461
work_keys_str_mv AT leizhang theorphannuclearreceptor4a1apotentialnewtherapeutictargetformetabolicdiseases
AT qunwang theorphannuclearreceptor4a1apotentialnewtherapeutictargetformetabolicdiseases
AT wenliu theorphannuclearreceptor4a1apotentialnewtherapeutictargetformetabolicdiseases
AT fangyanliu theorphannuclearreceptor4a1apotentialnewtherapeutictargetformetabolicdiseases
AT ailingji theorphannuclearreceptor4a1apotentialnewtherapeutictargetformetabolicdiseases
AT yanzhangli theorphannuclearreceptor4a1apotentialnewtherapeutictargetformetabolicdiseases
AT leizhang orphannuclearreceptor4a1apotentialnewtherapeutictargetformetabolicdiseases
AT qunwang orphannuclearreceptor4a1apotentialnewtherapeutictargetformetabolicdiseases
AT wenliu orphannuclearreceptor4a1apotentialnewtherapeutictargetformetabolicdiseases
AT fangyanliu orphannuclearreceptor4a1apotentialnewtherapeutictargetformetabolicdiseases
AT ailingji orphannuclearreceptor4a1apotentialnewtherapeutictargetformetabolicdiseases
AT yanzhangli orphannuclearreceptor4a1apotentialnewtherapeutictargetformetabolicdiseases